Home/NeuroTherapia/Tony Giordano, Ph.D.
TG

Tony Giordano, Ph.D.

President & CEO

NeuroTherapia

NeuroTherapia Pipeline

DrugIndicationPhase
NTRX-07Alzheimer's DiseasePhase 2